Skip to content

Arcus Biosciences RCUS Operating margin

Operating margin at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
24.3%-2.9pp
AbbVie logo
AbbVieABBV
24.4%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-4,671.1%-5,434pp
Incyte logo
IncyteINCY
30%+26.1pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-185.4%-83.3pp
Summit Therapeutics logo
Summit TherapeuticsSMMT
-268,266.8%-272,316pp

Other financials

Income statement

See full
Revenue$17.0M-39.3%
Operating income-$134.0M-9.8%
Net income-$128.0M-14.3%
EPS (diluted)-$1.02+10.5%

Balance sheet

See full
Cash & equivalents$201.0M+4.7%
Total debt$113.0M+88.3%
Total equity$524.0M-1.3%
Total assets$997.0M-13.8%

Cash flow

See full
Operating cash flow-$138.0M-4.5%
CapEx--100%
Free cash flow-$138.0M-3.8%

Valuation

See full
Market cap$3.54B+226%
Enterprise value$3.46B+275%
P/S15×+7.3×

Profitability

See full
Net margin-156.4%-47.5pp
FCF margin-207.2%

Returns & leverage

See full
Return on equity-70%+8.4pp
Debt / equity0.2×+0.1×
Current ratio-1.3×

Where this comes from

Calculated from Arcus Biosciences’s reported figures.

Based on trailing twelve months.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcus Biosciences's operating margin?
Arcus Biosciences (RCUS) reported operating margin of -168.6% in Q1 2026.
How has Arcus Biosciences's operating margin changed year-over-year?
Arcus Biosciences's operating margin increased by 45.5% year-over-year, from -309.2% to -168.6%.
What is the long-term trend for Arcus Biosciences's operating margin?
Over 5 years (2020 to 2025), Arcus Biosciences's operating margin has grown at a -0.3% compound annual growth rate (CAGR), from -159% to -156.3%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.